Trajectories of prescription drug misuse during the transition from late adolescence into adulthood in the USA: a national longitudinal multicohort study.
Journal
The lancet. Psychiatry
ISSN: 2215-0374
Titre abrégé: Lancet Psychiatry
Pays: England
ID NLM: 101638123
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
18
04
2019
revised:
18
07
2019
accepted:
19
07
2019
pubmed:
16
9
2019
medline:
5
11
2019
entrez:
16
9
2019
Statut:
ppublish
Résumé
Prescription drug misuse is most prevalent during young adulthood (ages 18-25 years). We aimed to identify prescription drug misuse trajectories for three drug classes (opioids, stimulants, and sedatives or tranquilisers) from adolescence into adulthood, assess the extent to which different trajectories are associated with symptoms of substance use disorder, and identity factors associated with high-risk prescription drug misuse trajectories. For this longitudinal multicohort study, nationally representative probability samples of 51 223 adolescents in the USA were followed up across eight waves from age 18 years (cohorts 1976-96) to age 35 years. Data were collected via self-administered paper questionnaires. Five prescription drug misuse trajectories were identified and the defining characteristic that differentiated the five trajectories was the age when past-year prescription drug misuse high frequency peaked: rare or no misuse at any age, peak at age 18 years, peak at ages 19-20 years, peak at age 23-24 years, and peak at ages 27-28 years. Similar prescription drug misuse trajectories were identified for each prescription drug class. The later peak misuse trajectory for sedatives and tranquilisers crested at an older age (35 years) than that for the other drug classes. Prescription drug misuse trajectories were all associated with significantly greater odds of having two or more substance use disorder symptoms at age 35 years, especially the later peak trajectories. In controlled analyses, risk factors associated with the high-risk latest peak prescription drug misuse trajectory included high school heavy drinking, cigarette smoking, marijuana use, poly-prescription drug misuse, white race, and not completing a 4-year university degree. Prescription drug misuse trajectories are heterogeneous, and any high-frequency prescription drug misuse is a strong risk factor for development of substance use disorders during adulthood, especially later-peak prescription drug misuse trajectories. These findings might help practitioners identify individuals at greatest risk for substance use disorders and target intervention strategies. National Institute on Drug Abuse, National Institutes of Health.
Sections du résumé
BACKGROUND
Prescription drug misuse is most prevalent during young adulthood (ages 18-25 years). We aimed to identify prescription drug misuse trajectories for three drug classes (opioids, stimulants, and sedatives or tranquilisers) from adolescence into adulthood, assess the extent to which different trajectories are associated with symptoms of substance use disorder, and identity factors associated with high-risk prescription drug misuse trajectories.
METHODS
For this longitudinal multicohort study, nationally representative probability samples of 51 223 adolescents in the USA were followed up across eight waves from age 18 years (cohorts 1976-96) to age 35 years. Data were collected via self-administered paper questionnaires.
FINDINGS
Five prescription drug misuse trajectories were identified and the defining characteristic that differentiated the five trajectories was the age when past-year prescription drug misuse high frequency peaked: rare or no misuse at any age, peak at age 18 years, peak at ages 19-20 years, peak at age 23-24 years, and peak at ages 27-28 years. Similar prescription drug misuse trajectories were identified for each prescription drug class. The later peak misuse trajectory for sedatives and tranquilisers crested at an older age (35 years) than that for the other drug classes. Prescription drug misuse trajectories were all associated with significantly greater odds of having two or more substance use disorder symptoms at age 35 years, especially the later peak trajectories. In controlled analyses, risk factors associated with the high-risk latest peak prescription drug misuse trajectory included high school heavy drinking, cigarette smoking, marijuana use, poly-prescription drug misuse, white race, and not completing a 4-year university degree.
INTERPRETATION
Prescription drug misuse trajectories are heterogeneous, and any high-frequency prescription drug misuse is a strong risk factor for development of substance use disorders during adulthood, especially later-peak prescription drug misuse trajectories. These findings might help practitioners identify individuals at greatest risk for substance use disorders and target intervention strategies.
FUNDING
National Institute on Drug Abuse, National Institutes of Health.
Identifiants
pubmed: 31521577
pii: S2215-0366(19)30299-8
doi: 10.1016/S2215-0366(19)30299-8
pmc: PMC6939756
mid: NIHMS1060114
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
840-850Subventions
Organisme : NIDA NIH HHS
ID : R01 DA001411
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA016575
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA031160
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA036541
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA043691
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.
Références
Drug Alcohol Depend. 2019 Jan 1;194:377-385
pubmed: 30481692
Addict Behav. 2011 Jan-Feb;36(1-2):79-86
pubmed: 20864261
Drug Alcohol Depend. 1996 Jun;41(2):101-12
pubmed: 8809498
J Stud Alcohol Suppl. 2002 Mar;(14):54-70
pubmed: 12022730
Drug Alcohol Depend. 2012 Nov 1;126(1-2):65-70
pubmed: 22609061
Pain. 2018 Oct;159(10):2050-2057
pubmed: 29794611
Lancet Psychiatry. 2018 Dec;5(12):987-1012
pubmed: 30392731
J Adolesc Health. 2012 Jul;51(1):6-17
pubmed: 22727071
Pediatrics. 2013 Nov;132(5):825-32
pubmed: 24167166
Addiction. 2008 May;103 Suppl 1:84-99
pubmed: 18426542
J Stud Alcohol. 2001 Mar;62(2):150-7
pubmed: 11327181
MMWR Morb Mortal Wkly Rep. 2018 Mar 30;67(12):349-358
pubmed: 29596405
Subst Abuse. 2016 May 25;9(Suppl 1):41-57
pubmed: 27257384
J Clin Psychiatry. 2018 Mar/Apr;79(2):
pubmed: 29570970
Br J Clin Pharmacol. 2013 Nov;76(5):823-4
pubmed: 23594290
J Am Coll Health. 2012;60(3):226-34
pubmed: 22420700
Addiction. 2014 Jan;109(1):102-10
pubmed: 24025114
J Clin Psychiatry. 2016 Jun;77(6):772-80
pubmed: 27337416
J Consult Clin Psychol. 1998 Jun;66(3):474-83
pubmed: 9642885
Addict Behav. 2016 Jan;52:8-12
pubmed: 26334560
Drug Alcohol Depend. 2018 Aug 1;189:172-177
pubmed: 29960204
Am J Psychiatry. 2016 Jun 1;173(6):588-99
pubmed: 26940807
Exp Clin Psychopharmacol. 2016 Feb;24(1):38-47
pubmed: 26502300
J Emerg Med. 2016 Nov;51(5):485-490
pubmed: 27596964
JAMA Psychiatry. 2015 Aug;72(8):757-66
pubmed: 26039070